新型CFHR1-CFHR5杂合蛋白导致家族性显性C3肾小球病
本研究报道一个家族中由146 Kbp杂合缺失产生的新型CFHR1-R5杂合蛋白,该缺失见于四名表现为显性遗传性肾小球病的家庭成员,病理为致密物沉积病与C3肾小球肾炎重叠。患者补体旁路途径持续激活,异常蛋白与CFHR1和CFHR2结合并干扰补体因子H对C3转化酶的衰变活性。
要点
- 家族性C3肾小球病需筛查CFHR基因重排
- CFHR1-CFHR5杂合蛋白可导致补体旁路途径系统性失调
- 低C3和因子B及高sC5b9和Bb提示旁路途径激活
核心结论
- CFHR1-CFHR5杂合蛋白与家族性显性C3肾小球病相关,并干扰补体因子H对C3转化酶的衰变活性。
研究设计与样本
- 本研究报道一个家族中四名成员携带146 Kbp杂合缺失,导致CFHR1-R5杂合蛋白,病理为致密物沉积病与C3肾小球肾炎重叠。
主要发现
- 四名受累家庭成员均表现为持续性低C3和因子B水平及高sC5b9和Bb水平。
- 异常蛋白通过Western blot和免疫沉淀鉴定,以与CFHR1和CFHR2结合的形式循环,归因于其两个N端二聚化基序。
- 该蛋白的存在与补体因子H对C3转化酶衰变活性的扰动相关。
关键数值与推荐
- 杂合缺失跨度146 Kbp,涉及多个CFHR基因。
- 受累患者C3和因子B水平持续低下,sC5b9和Bb水平升高。
临床怎么用
- 对所有家族性C3肾小球病应筛查CFHR基因,以识别致病性重排。
局限性
- 本研究为单一家族报道,未提供更大样本或功能实验的定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The intrinsic similarity shared between the members of the complement factor H family, which comprises complement factor H and five complement factor H-related (CFHR) genes, leads to various recombination events. In turn these events lead to deletions of some genes or abnormal proteins, which are found in patients with atypical hemolytic uremic syndrome or C3 glomerulopathies. Here we describe a novel genetic rearrangement generated from a heterozygous deletion spanning 146 Kbp involving multiple CFHR genes leading to a CFHR1-R5 hybrid protein. This deletion was found in four family members presenting with a familial dominant glomerulopathy histologically classified as an overlap of dense deposit disease and C3 glomerulonephritis. Affected patients exhibited permanently low C3 and factor B levels and high amounts of activation fragments sC5b9 and Bb, indicating a systemic alternative pathway dysregulation. The abnormal protein, characterized by Western blot and immunoprecipitation, was shown to circulate in association with CFHR1 and CFHR2, attributable to its two N-terminal dimerization motifs. The presence of this protein is associated with a perturbation of Factor H activity on the C3 convertase decay. Thus, our study highlights the role of CFHRs in the physiopathology of C3 glomerulopathies and stresses the importance of screening CFHRs in all familial C3 glomerulopathies. Such hybrids described till now were always associated with familial forms.
引用
- Togarsimalemath SK, Sethi SK, Duggal R, et al. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy. Kidney Int. 2017. PMID: 28729035. doi:10.1016/j.kint.2017.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。